Processa Pharmaceuticals, Inc. Increase (Decrease) in Prepaid Expense
Processa Pharmaceuticals, Inc. (PCSA) reported Increase (Decrease) in Prepaid Expense of -$37.55 thousand for the 9-month period ending 2019-09-30, per its 10-Q filed 2019-11-14.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidExpense · last filed 2019-11-14
- Processa Pharmaceuticals, Inc. increase (decrease) in prepaid expense for the quarter ending 2019-09-30 was -$47.64K, a 123.96% decline year-over-year.
- Processa Pharmaceuticals, Inc. increase (decrease) in prepaid expense for the quarter ending 2019-06-30 was $20.72K, a 52.17% decline year-over-year.
- Processa Pharmaceuticals, Inc. increase (decrease) in prepaid expense for the quarter ending 2019-03-31 was -$10.63K.
- Processa Pharmaceuticals, Inc. increase (decrease) in prepaid expense for the quarter ending 2018-12-31 was -$24.49K, a 196.55% decline year-over-year.
- Processa Pharmaceuticals, Inc. increase (decrease) in prepaid expense for fiscal 2018 was $216.39K, a 828.74% increase from fiscal 2017.
- Processa Pharmaceuticals, Inc. increase (decrease) in prepaid expense for fiscal 2017 was $23.30K, a 43.13% increase from fiscal 2016.
- Processa Pharmaceuticals, Inc. increase (decrease) in prepaid expense for fiscal 2016 was $16.28K.
| Period end | Increase (Decrease) in Prepaid Expense 3 month | Increase (Decrease) in Prepaid Expense 6 month | Increase (Decrease) in Prepaid Expense 9 month | Increase (Decrease) in Prepaid Expense 12 month |
|---|---|---|---|---|
| 2019-09-30 | -$47.64K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | -$26.92K derived: sum of 2 quarters · filed 2019-11-14 | -$37.55K 10-Q · filed 2019-11-14 | -$62.04K derived: sum of 4 quarters · filed 2019-11-14 |
| 2019-06-30 | $20.72K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | $10.09K 10-Q · filed 2019-08-14 | -$14.40K derived: sum of 3 quarters · filed 2019-08-14 | $184.41K derived: sum of 4 quarters · filed 2019-11-14 |
| 2019-03-31 | -$10.63K 10-Q · filed 2019-05-14 | -$35.12K derived: sum of 2 quarters · filed 2019-05-14 | $163.69K derived: sum of 3 quarters · filed 2019-11-14 | $207.01K derived: sum of 4 quarters · filed 2019-11-14 |
| 2018-12-31 | -$24.49K derived: 10-K/A 12 month − 10-Q 9 month · filed 2019-04-08 | $174.32K derived: sum of 2 quarters · filed 2019-11-14 | $217.64K derived: sum of 3 quarters · filed 2019-11-14 | $216.39K 10-K/A · filed 2019-04-08 |
| 2018-09-30 | $198.81K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | $242.13K derived: sum of 2 quarters · filed 2019-11-14 | $240.87K 10-Q · filed 2019-11-14 | $266.23K derived: sum of 4 quarters · filed 2019-11-14 |
| 2018-06-30 | $43.32K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | $42.07K 10-Q · filed 2019-08-14 | $67.43K derived: sum of 3 quarters · filed 2019-08-14 | $64.86K derived: sum of 4 quarters · filed 2019-08-14 |
| 2018-03-31 | -$1.26K 10-Q · filed 2019-05-14 | $24.10K derived: sum of 2 quarters · filed 2019-05-14 | $21.53K derived: sum of 3 quarters · filed 2019-05-14 | $40.19K derived: sum of 4 quarters · filed 2019-05-14 |
| 2017-12-31 | $25.36K derived: 10-K/A 12 month − 10-Q 9 month · filed 2019-04-08 | $22.79K derived: sum of 2 quarters · filed 2019-04-08 | $41.45K derived: sum of 3 quarters · filed 2019-04-08 | $23.30K 10-K/A · filed 2019-04-08 |
| 2017-09-30 | -$2.57K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | $16.09K derived: sum of 2 quarters · filed 2018-11-14 | -$2.06K 10-Q · filed 2018-11-14 | |
| 2017-06-30 | $18.66K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-14 | $511.00 10-Q · filed 2018-08-14 | ||
| 2017-03-31 | -$18.15K 10-Q · filed 2018-05-21 | |||
| 2016-12-31 | $16.28K 10-K · filed 2018-04-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |